IP Library Patent Application 18246982
Patent Application
App. No. 18/246,982

STABILIZED ALKYL NITRITE COMPOSITIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/246,982
Abstract

This disclosure describes a composition comprising an alkyl nitrite, such as isoamyl nitrite, and an effective amount of at least one stabilizing compound, such as one or more of vitamins K1, K2, and K3.

Claims (30)

1 . A composition comprising an alkyl nitrite and an effective amount of at least one compound of Formula I:

wherein:

R 1 , R 2 , R 3 , and R 4 are each independently selected from the group consisting of —H, —OH, —NH 2 , —SH, halogen, optionally substituted C 1 -C 12 alkyl, optionally substituted C 1 -C 12 alkoxy, C 1 -C 4 alkylthio, —C≡N, —C(═O)H, —C(═O)OH, —C(═O )O(C 1 -C 3 alkyl), and —C(═O )(C 1 -C 3 alkyl); further wherein

R 5 and R 6 are each independently selected from the group consisting of —H, —OH, —SH, —NH 2 , halogen, optionally substituted C 1 -C 12 alkyl, optionally substituted C 2 -C 75 alkenyl, C 1 -C 4 alkylthio, —C≡N, C 1 -C 12 alkoxy, —C(═O)H, and —C(═O )(C 1 -C 3 -alkyl).

2 . The composition of claim 1 , wherein the alkyl nitrite is a C 1 -C 7 alkyl nitrite.

3 . The composition of claim 2 , wherein the C 1 -C 7 alkyl nitrite is selected from the group consisting of propyl nitrite, isopropyl nitrite, butyl nitrite, sec-butyl nitrite, isobutyl nitrite, tent-butyl nitrite, amyl nitrite, isoamyl nitrite, and neo-pentyl nitrite.

4 . The composition of claim 3 , wherein the alkyl nitrite is isoamyl nitrite.

5 . The composition of claim 1 , wherein R 1 , R 2 , R 3 , and R 4 are each —H.

6 . The composition of claim 1 , wherein R 5 is an optionally substituted C 1 -C 12 alkyl and R 6 is an optionally substituted C 2 -C 75 alkenyl or —H.

7 . The composition of claim 6 , wherein the optionally substituted C 1 -C 12 alkyl is selected from the group consisting of methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, isobutyl, tent-butyl, pentyl, isopentyl, neo-pentyl, (1,1-dimethyl)-prop-1-yl, hexyl, heptyl, octyl, isooctyl, nonyl, decyl, cyclopentyl, cyclohexyl, and cycloheptyl.

8 . The composition of claim 6 , wherein the optionally substituted C 1 -C 12 alkyl is methyl.

9 . The composition of claim 6 , wherein the optionally substituted C 2 -C 75 alkenyl is selected from the group consisting of ethenyl, propenyl, isopropenyl, butenyl, pentenyl, hexenyl, heptenyl, (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl, (2E)-3,7-dimethylocta-2,6-dien-1-yl, (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1 -yl, (2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl, (2Z,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl, (2E,6E,10E,14E)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaen-1-yl, (2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl, (2Z,6E,10E,14E,18E,22E)-3,7,11,15,19,23,27-heptamethyloctacosa-2,6,10,14,18,22,26-heptaen-1-yl, (2E,6Z,10E,14E,18E,22E)-3,7,11,15,19,23,27-heptamethyloctacosa-2,6,10,14,18,22,26-heptaen-1-yl, (2E,6E,10E,14E,18E,22E)-3,7,11,15,19,23,27-heptamethyloctacosa-2,6,10,14,18,22,26-heptaen-1-yl, (2E,6E,10E,14E,18E,22E,26E)-3,7,11,15,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-octaen-1 -yl, (2E,6E, 10E,14E,18Z,22E,26E)-3,7,11,15,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-octaen-1-yl, (2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl, (2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl, (2E,6E,10E,14E,18E,22E,26E,30E,34E,38E)-3,7,11,15,19,23,27,31,35,39,43 -undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaen-1-yl, (2E,6E,10E,14E,18E,22E,26E,30E,34E,38E,42E)-3,7,11,15,19,23,27,31,35,39,43,47-dodecamethyloctatetraconta- 2,6,10,14,18, 22,26,30,34,38,42,46-dodecaen-1-yl, (2E,6E,10E,14E,18E,22E,26E,30E,34E,38E,42E,46E)-3,7,11,15,19,23,27,31,35,39,43,47,51-tridecamethyldopentaconta-2,6,10,14,18, 22,26,30,34,38,42,46,50-tridecaen-1-yl, (2E,6E,10E,14E,18E,22E,26E,30E,34E,38E,42E,46E,50E)-3,7,11,15,19,23,27,31,35,39,43,47,51,55-tetradecamethylhexapentaconta -2,6,10,14,18,22,26,30,34,38,42,46,50,54-tetradecaen-1-yl, and (2E,6E,10E,14E,18E,22E,26E,30E,34E,38E,42E,46E,50E,54E)-3,7,11,15,19,23,27,31,35,39,43,47,51,55,59-pentadecamethylhexaconta-2,6,10,14,18,22,26,30,34,38,42,46,50,54,58-pentadecaen-1-yl.

10 . The composition of claim 6 , wherein the optionally substituted C 2 -C 75 alkenyl is (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl.

11 . The composition of claim 1 , wherein R 1 , R 2 , R 3 , and R 4 are each —H, R 5 is methyl, and R 6 is (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl.

12 . The composition of claim 1 , wherein the effective amount of the at least one compound of Formula I ranges from about 0.1% by weight to about 20% by weight of the composition.

13 . The composition of claim 12 , wherein the effective amount of the at least one compound of Formula I ranges from about 1% by weight to about 10% by weight of the composition.

14 . The composition of claim 13 , wherein the effective amount of the at least one compound of Formula I is about 10% by weight of the composition.

15 . The composition of claim 13 , wherein R 1 , R 2 , R 3 , and R 4 are each —H, R 5 is methyl, and R 6 is (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl.

16 . The composition of claim 1 , wherein the alkyl nitrite composition is packaged in an ampule under an inert atmosphere.

17 . A composition comprising an alkyl nitrite and an effective amount of a vitamin, the vitamin selected from the group consisting of vitamin K1, vitamin K2, vitamin K3, and combinations thereof.

18 .- 22 . (canceled)

23 . The composition of claim 17 , wherein the effective amount of the vitamin ranges from about 0.1% by weight to about 20% by weight of the composition.

24 .- 25 . (canceled)

26 . The composition of claim 17 , wherein the alkyl nitrite is a C 1 -C 7 alkyl nitrite.

27 . The composition of claim 26 , wherein the C 1 -C 7 alkyl nitrite is selected from the group consisting of propyl nitrite, isopropyl nitrite, butyl nitrite, sec-butyl nitrite, isobutyl nitrite, tent-butyl nitrite, amyl nitrite, isoamyl nitrite, and neo-pentyl nitrite.

28 . The composition of claim 27 , wherein the alkyl nitrite is isoamyl nitrite.

29 . The composition of claim 1 , wherein the alkyl nitrite has a purity after storage at 40° C. for six months, ranging from about 90% to about 98%, as measured by gas chromatography (GC).

30 . The composition of claim 29 , wherein the alkyl nitrite is isoamyl nitrite.

31 . The composition of claim 30 , wherein the compound of Formula I is vitamin K1.

32 . (canceled)

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 29, 2026
From: OHA AGENCY LLC, IN ITS CAPACITY AS ADMINISTRATIVE AGENT
To: EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Reel/Frame 074509/0661 →
SECURITY INTEREST Recorded Apr 16, 2026
From: EMERGENT BIOSOLUTIONS INC.; EMERGENT BIODEFENSE OPERATIONS LANSING LLC; EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.; EMERGENT TRAVEL HEALTH INC.; EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 074389/0054 →
SECURITY INTEREST Recorded Sep 30, 2024
From: EMERGENT BIODEFENSE OPERATIONS LANSING LLC; EMERGENT BIOSOLUTIONS INC.; EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.; EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC; EMERGENT TRAVEL HEALTH INC.; EMERGENT BIOSOLUTIONS CANADA INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 068746/0698 →
NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS Recorded Sep 3, 2024
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Reel/Frame 068829/0913 →
NOTICE OF GRANT OF SECURITY INTEREST IN U.S. PATENTS Recorded Sep 3, 2024
From: EMERGENT BIODEFENSE OPERATIONS LANSING LLC; EMERGENT BIOSOLUTIONS CANADA INC.; EMERGENT BIOSOLUTIONS INC.; EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC; EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.; EMERGENT TRAVEL HEALTH INC.
To: OHA AGENCY LLC
Reel/Frame 068828/0233 →
SECURITY INTEREST Recorded May 17, 2024
From: EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 067443/0091 →